Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-Coagulants for Prevention

Authors

Nasir Shariff, Lehigh Valley Health NetworkFollow
Abdul Aleem MD, Lehigh Valley Health NetworkFollow
Vadim Levin MD, Lehigh Valley Health NetworkFollow
Sudip Nanda MD, FACP, Lehigh Valley Health Network
Matthew W. Martinez MD, Lehigh Valley Health NetworkFollow
Stacey Smith MD, FACP, Lehigh Valley Health NetworkFollow
Ronald S. Freudenberger MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

4-1-2012

Abstract

Heart failure (HF) is a common clinical syndrome characterized by high morbidity and frequent hospitalizations. HF is an independent and major risk factor for venous thromboembolism (VTE) and VTE occurring in patients with HF carries a worse prognosis. The present review will focus on short and long term role of anti-coagulants in prevention of venous thrombosis in HF patients. We will also be discussing the recently investigated and patented anti-coagulants which could have a role in this specific population.

Volume

7

Issue

1

First Page

53

Last Page

58

ISSN

15748901

Published In/Presented At

Shariff, N., Aleem, A., Levin, V., Desai, R. V., Nanda, S., Martinez, M. W., Smith SJ., & Freudenberger, R. (2012). Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for prevention.Recent Patents On Cardiovascular Drug Discovery, 7(1), 53-58.

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Cardiology | Chemicals and Drugs | Medical Sciences | Medical Specialties | Medicine and Health Sciences | Therapeutics

PubMedID

22250920

LVHN link

http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=22250920&site=ehost-live&scope=site

Department(s)

Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents

Document Type

Article